Search for biomarkers of asbestos exposure and asbestos-induced cancers in investigations of the immunological effects of asbestos

[1]  J. Creaney,et al.  Malignant Mesothelioma Biomarkers: From Discovery to Use in Clinical Practice for Diagnosis, Monitoring, Screening, and Treatment , 2017, Chest.

[2]  T. Otsuki,et al.  Silicosis and autoimmunity , 2017, Current opinion in allergy and clinical immunology.

[3]  H. Matsuzaki,et al.  Accelerated cell cycle progression of human regulatory T cell-like cell line caused by continuous exposure to asbestos fibers , 2016, International journal of oncology.

[4]  H. Matsuzaki,et al.  The Suppressed Induction of Human Mature Cytotoxic T Lymphocytes Caused by Asbestos Is Not due to Interleukin-2 Insufficiency , 2016, Journal of immunology research.

[5]  H. Matsuzaki,et al.  FoxO1 regulates apoptosis induced by asbestos in the MT-2 human T-cell line , 2016, Journal of immunotoxicology.

[6]  H. Matsuzaki,et al.  T Cell Alteration Caused by Exposure to Asbestos , 2016 .

[7]  H. Matsuzaki,et al.  Effects of Asbestos Fibers on Human Cytotoxic T Cells , 2016 .

[8]  K. Kawai.  γδ T Cells , 2016 .

[9]  H. Matsuzaki,et al.  Environmental factors and human health: fibrous and particulate substance-induced immunological disorders and construction of a health-promoting living environment , 2016, Environmental Health and Preventive Medicine.

[10]  P. Vigneri,et al.  Biomarkers and prognostic factors for malignant pleural mesothelioma. , 2015, Future oncology.

[11]  H. Matsuzaki,et al.  Enhancement of regulatory T cell-like suppressive function in MT-2 by long-term and low-dose exposure to asbestos. , 2015, Toxicology.

[12]  W. Wang,et al.  Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma , 2015, Tumor Biology.

[13]  M. Vyberg,et al.  The established and future biomarkers of malignant pleural mesothelioma. , 2015, Cancer treatment reviews.

[14]  G. Stella,et al.  Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic , 2015, European Respiratory Review.

[15]  H. Matsuzaki,et al.  Investigating methods regarding diagnostic and prognostic biomarkers for malignant mesothelioma , 2015 .

[16]  H. Matsuzaki,et al.  Chronic exposure to asbestos enhances TGF-β1 production in the human adult T cell leukemia virus-immortalized T cell line MT-2. , 2014, International journal of oncology.

[17]  Ying Chen,et al.  Silica exposure and altered regulation of autoimmunity , 2014, Environmental Health and Preventive Medicine.

[18]  Takemi Otsuki,et al.  Functional Properties of CD8+ Lymphocytes in Patients with Pleural Plaque and Malignant Mesothelioma , 2014, Journal of immunology research.

[19]  D. Alizadeh,et al.  The Multifaceted Role of Th17 Lymphocytes and Their Associated Cytokines in Cancer , 2013, Clinical & developmental immunology.

[20]  Mark S. Sundrud,et al.  Identity crisis of Th17 cells: many forms, many functions, many questions. , 2013, Seminars in immunology.

[21]  Wenhui Qi,et al.  Correlation between Th17 cells and tumor microenvironment. , 2013, Cellular immunology.

[22]  H. Matsuzaki,et al.  Effect of asbestos exposure on differentiation of cytotoxic T lymphocytes in mixed lymphocyte reaction of human peripheral blood mononuclear cells. , 2013, American journal of respiratory cell and molecular biology.

[23]  H. Matsuzaki,et al.  Altered functions of alveolar macrophages and NK cells involved in asbestos-related diseases , 2013, Environmental Health and Preventive Medicine.

[24]  N. Hemdan.  Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells. , 2013, Immunology letters.

[25]  Sergio Pina Oviedo,et al.  Diffuse malignant mesothelioma. , 2012, Archives of pathology & laboratory medicine.

[26]  W. Fujimoto,et al.  Environmental factors producing autoimmune dysregulation--chronic activation of T cells caused by silica exposure. , 2012, Immunobiology.

[27]  F. Gemignani,et al.  A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma. , 2012, Mutation research.

[28]  H. Matsuzaki,et al.  Asbestos-Induced Cellular and Molecular Alteration of Immunocompetent Cells and Their Relationship with Chronic Inflammation and Carcinogenesis , 2012, Journal of biomedicine & biotechnology.

[29]  H. Matsuzaki,et al.  Asbestos Induces Reduction of Tumor Immunity , 2011, Clinical & developmental immunology.

[30]  T. Otsuki,et al.  Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients. , 2011, American journal of respiratory cell and molecular biology.

[31]  T. Otsuki,et al.  Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2. , 2011, American journal of respiratory cell and molecular biology.

[32]  T. Nakano,et al.  Suppressive effect of asbestos on cytotoxicity of human NK cells. , 2011, International journal of immunopathology and pharmacology.

[33]  R. Gill.  Imaging of mesothelioma. , 2011, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[34]  T. Otsuki,et al.  Decrease in Phosphorylation of ERK following Decreased Expression of NK Cell-Activating Receptors in Human NK Cell Line Exposed to Asbestos , 2009, International journal of immunopathology and pharmacology.

[35]  T. Nakano,et al.  Impairment in Cytotoxicity and Expression of NK Cell- Activating Receptors on Human NK Cells following Exposure to Asbestos Fibers , 2009, International journal of immunopathology and pharmacology.

[36]  D. Sugarbaker,et al.  Current trends in radiologic management of malignant pleural mesothelioma. , 2009, Seminars in thoracic and cardiovascular surgery.

[37]  Richard A. Flavell,et al.  The Nalp3 inflammasome is essential for the development of silicosis , 2008, Proceedings of the National Academy of Sciences.

[38]  J. Tschopp,et al.  Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica , 2008, Science.

[39]  A. Gibbs,et al.  Asbestos and its diseases , 2008 .

[40]  A. Gibbs,et al.  Comprar Asbestos and Its Diseases | John E. Craighead | 9780195178692 | Oxford University Press , 2008 .

[41]  T. Nakano,et al.  Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells , 2006, Apoptosis.

[42]  Ronald F. Dodson,et al.  Asbestos: Risk Assessment, Epidemiology, and Health Effects , 2005 .

[43]  Y. Matsuo,et al.  Inhibitory Effects of Anti‐Oxidants on Apoptosis of a Human Polyclonal T‐Cell Line, MT‐2, Induced by an Asbestos, Chrysotile‐A , 2005, Scandinavian journal of immunology.

[44]  C. Baecher-Allan,et al.  Human CD4+CD25+ regulatory T cells. , 2004, Seminars in immunology.

[45]  T. Sporn,et al.  Cytopathology of Asbestos-Associated Diseases , 2004 .

[46]  V. Roggli,et al.  Pathology of Asbestos-Associated Diseases , 2004, Springer New York.

[47]  S. Zheng,et al.  The role of the combination of IL‐2 and TGF‐β or IL‐10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets , 2003, Journal of leukocyte biology.

[48]  M. Roncarolo,et al.  The Role of IL-10 and TGF-β in the Differentiation and Effector Function of T Regulatory Cells , 2002, International Archives of Allergy and Immunology.

[49]  N. Müller.  Imaging of the pleura. , 1993, Radiology.